Doximity, Inc. (DOCS) stock
Close on Nov 11, 2026Market cap $5.92BP/E 46.1Yield –
Doximity, Inc. grew revenue 6.5% to $661.58M over the twelve months to Sep 30, 2026. Operating income fell 29.4% to $174.29M, moving the operating margin from 39.7% to 26.3%. Free cash flow was $326.46M, up 19.5% from a year earlier. At the latest close the market valued the company at $5.92B, 46.1 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.92B
- P/E ratio
- 46.1
- Price to sales
- 8.95
- Price to book
- 6.38
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $661.58M
- Net income
- $139.72M
- EPS, diluted
- $0.72
- Free cash flow
- $326.46M
- Book value per share
- $4.94
- Diluted shares
- 188M
Trading
- Next earnings
- Feb 4, 2027 (estimated, after the close)
- Previous close
- $32.42
- Open
- $32.36
- Day's range
- $31.96 – $33.63
- Volume
- 2,277,887
- Average volume (20 days)
- 2,649,154
- Index membership
- S&P MidCap 400 (since Aug 2023), Russell 1000 (since Jun 2022), Russell 3000 (since Aug 2022)
- Beta (5 years)
- 1.65
- 52-week range
- $17.15 – $54.04
- RSI (14 days)
- 57.7
- Volatility (1 year)
- 63.4%
- Relative volume
- 0.57×
- WACC
- 13.2%
Index membership is inferred from the holdings of funds that track each index (IJH, SPMD, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | DOCS | S&P 500 | Difference | DOCS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +8.9% | -2.4% | +11.3 pts | ||
| 3 months | +27.2% | -1.2% | +28.4 pts | ||
| Year to date | -25.0% | +12.3% | −37.3 pts | ||
| 1 year | -37.0% | +12.4% | −49.4 pts | ||
| 3 years | +39.4% | +78.8% | −39.4 pts | +11.7% | +21.4% |
| 5 years | -56.7% | +75.2% | −131.8 pts | -15.4% | +11.9% |
Eight years at a glance
Fiscal years 2019 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Doximity filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Doximity
Services-Computer Programming Services
Doximity operates a digital platform tailored for medical professionals, offering tools that support clinical productivity, career management, and collaboration. Its core commercial offerings are organized into Marketing Solutions, Hiring Solutions, and Workflow Solutions. Through Marketing Solutions, pharmaceutical manufacturers and health systems share sponsored content with targeted clinicians. Hiring Solutions delivers digital recruitment capabilities and personalized staffing via Curative Talent. Workflow Solutions features the Clinical AI Suite—including the Ask clinical AI assistant, Scribe ambient documentation, and Dialer telehealth—alongside digital fax, secure messaging, and on-call scheduling tools.
Company profile, executives and historyDoximity stock: common questions
What is Doximity's stock price?
DOCS closed at $33.22 on Nov 11, 2026, up 2.47% on the day. Over the past 52 weeks it traded between $17.15 and $54.04.
What is Doximity's market cap?
Doximity was worth $5.92B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is DOCS's P/E ratio?
DOCS trades at 46.1 times earnings, based on diluted earnings per share of $0.72 over the twelve months to Sep 30, 2026.
How much revenue does Doximity make?
Doximity reported revenue of $661.58M for the twelve months to Sep 30, 2026, up 6.5% from a year earlier.
Does Doximity pay a dividend?
No. Doximity has not paid a cash dividend over the last twelve months.
When does Doximity report earnings next?
Doximity is expected to report Q3 FY2027 results on Feb 4, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has DOCS stock performed over the past year?
Including dividends, DOCS returned -37.0% over the past year, against +12.4% for the S&P 500.
How many DOCS shares are sold short?
7M shares were sold short at the latest FINRA report, 5.87% of the float, or 2.7 days of average trading volume.
Who are Doximity's competitors?
Companies most similar to Doximity by business, industry and size include GDRX, HNGE, WAY, CCSI, DH.
See a number that looks wrong?